LianBio
LIANY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831283
No open-market purchases or sales by LianBio insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $1.00K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by LianBio insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for LianBio, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Gu Ehong | Interim CFO | 0 | Apr 11, 2024 | 0 |
| Edelman Joseph | Director, 10% Owner | 17,082Indirect | Feb 20, 2024 | 0 |
| Perceptive Advisors LLC | Director, 10% Owner | 17,082Indirect | Feb 20, 2024 | 0 |
| Perceptive Life Sciences Master Fund Ltd | Director, 10% Owner | 17,082Indirect | Feb 20, 2024 | 0 |
| Gianakakos Anastasios | Director | 53,630 | Feb 20, 2024 | 0 |
| Poukalov Konstantin | Director | 17,082 | Feb 20, 2024 | 0 |
| Stone Adam Leo | Interim CEO | 17,082 | Feb 20, 2024 | 0 |
| Silbermann Susan Michele | Director | 17,082 | Feb 20, 2024 | 0 |
| Chen Wei Wei | Director | – | Jun 23, 2023 | 0 |
| Larson Yi | Chief Financial Officer | 325,901 | Mar 31, 2023 | 0 |
| Qian Jiang | SVP, China General Manager | 291,354 | Mar 31, 2023 | 0 |
| Wang Yizhe | Chief Executive Officer | 907,498 | Mar 31, 2023 | 0 |
| Jahn Brianne | Chief Business Officer | 224,005 | Mar 31, 2023 | 0 |
| Perceptive Xontogeny Venture Fund, LP | Director, 10% Owner | 3,728,491Indirect | Aug 22, 2022 | 0 |
| LEV LB Holdings, LP | Director, 10% Owner | 3,728,491Indirect | Aug 22, 2022 | 0 |
| Perceptive Venture Advisors, LLC | Director, 10% Owner | 3,728,491Indirect | Aug 22, 2022 | 0 |
| LEV LB Holdings GP, LLC | Director, 10% Owner | 3,728,491Indirect | Aug 22, 2022 | 0 |
| C2 Life Sciences LLC | Director, 10% Owner | 3,728,491Indirect | Aug 22, 2022 | 0 |
| Yu Debra | See Remarks | 1,000,000 | May 6, 2022 | 0 |
| Wu Jesse | Director | – | Nov 1, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2024 (view filing)4:10 PM ET | Jan 2 | 100 daysLate | Gu EhongInterim CFO | SSale | −1.73K | $4.34 | −$7.51K | −2.2%76.8K after | |
| Jan 5, 2023 (view filing) | Jan 3 | 2 days | Qian JiangSVP, China General Manager | SSale | −2.24K | $1.65 | −$3.69K | −3.2%67.3K after | |
| Aug 22, 2022 (view filing)9:17 AM ET | Aug 18 | 4 days | Edelman Joseph and 7 othersDirector, 10% Owner | PPurchaseAmerican Depositary Shares | +998.2K | $2.40 | +$2.40M | +36.6%3.73M after | |
| May 27, 2022 (view filing)10:06 AM ET | May 26 | 1 day | Edelman Joseph and 7 othersDirector, 10% Owner | PPurchaseAmerican Depositary Shares | +69.0K | $3.13 | +$216.0K | +2.6%2.73M after | |
| May 25, 2022 (view filing)6:51 PM ET | May 23-25 | 2 days | Edelman Joseph and 7 othersDirector, 10% Owner | PPurchaseAmerican Depositary Shares | +171.3K | $2.58 | +$442.4K | +6.9%2.66M after | 3 lots |
| Nov 5, 2021 (view filing)1:47 PM ET | Nov 3 | 2 days | Edelman Joseph and 7 othersDirector, 10% Owner | PPurchase | +2.27M | $15.98 | +$36.3M | +8.9%27.9M after | 2 lots |
| Nov 3, 2021 (view filing)6:59 PM ET | Nov 1-2 | 2 days | Perceptive Advisors LLC and 7 othersDirector, 10% Owner | PPurchase | +220.0K | $14.59 | +$3.21M | +3.1%7.25M after | 2 lots |